Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chenjing Qian, Qiuling Wu, Zhixuan Ruan, Fang Liu, Weiming Li, Wei Shi, Ling Ma, Danyue Peng, Hua Yin, Lan Yao, Zixuan Li, Mei Hong & Linghui Xia. (2023) A Visualized Mortality Prediction Score Model in Hematological Malignancies Patients with Carbapenem-Resistant Organisms Bloodstream Infection. Infection and Drug Resistance 16, pages 201-215.
Read now
Read now
Bhavya Somalapura Gangadharappa, Rajashekarappa Sharath, Prasanna D. Revanasiddappa, Vivek Chandramohan, Meenakshisundaram Balasubramaniam & Teja Priya Vardhineni. (2020) Structural insights of metallo-beta-lactamase revealed an effective way of inhibition of enzyme by natural inhibitors. Journal of Biomolecular Structure and Dynamics 38:13, pages 3757-3771.
Read now
Read now
Dmitrii V. Kalinin & Ralph Holl. (2017) LpxC inhibitors: a patent review (2010-2016). Expert Opinion on Therapeutic Patents 27:11, pages 1227-1250.
Read now
Read now
Herbert A Kirst. (2013) Developing new antibacterials through natural product research. Expert Opinion on Drug Discovery 8:5, pages 479-493.
Read now
Read now
Abhinay Sharma, Deepak Kumar Arya, Meenakshi Dua, Gursharan Singh Chhatwal & Atul Kumar Johri. (2012) Nano-technology for targeted drug delivery to combat antibiotic resistance. Expert Opinion on Drug Delivery 9:11, pages 1325-1332.
Read now
Read now
Alain J Cozzone. (2012) An insight into future antibacterial therapy. Emerging Microbes & Infections 1:1, pages 1-3.
Read now
Read now
Articles from other publishers (32)
Sheila Marty Yanestria, Mustofa Helmi Effendi, Wiwiek Tyasningsih, Mariyono Mariyono & Emmanuel Nnabuike Ugbo. (2023) First report of phenotypic and genotypic (blaOXA-61) beta-lactam resistance in Campylobacter jejuni from broilers in Indonesia. Veterinary World, pages 2210-2216.
Crossref
Crossref
Sapna Swarup, Sonali Chhabra & Raman Parkesh. 2023. Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development. Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development
609
633
.
Matteo Bassetti, Antonio Vena, Laura Labate & Daniele R. Giacobbe. (2022) Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?. Current Opinion in Infectious Diseases 35:6, pages 568-574.
Crossref
Crossref
Joseph P. LynchIIIIII, Nina M. Clark & George G. Zhanel. (2022) Infections Due to Acinetobacter baumannii–calcoaceticus Complex: Escalation of Antimicrobial Resistance and Evolving Treatment Options. Seminars in Respiratory and Critical Care Medicine 43:01, pages 097-124.
Crossref
Crossref
Nusrat Sahiba, Ayushi Sethiya & Shikha Agarwal. 2022. Imidazole-Based Drug Discovery. Imidazole-Based Drug Discovery
195
261
.
Adam G. Stewart, Patrick N. A. Harris, Mark D. Chatfield, Roberta Littleford & David L. Paterson. (2021) Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial. Trials 22:1.
Crossref
Crossref
Wieslaw Swietnicki. (2021) Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens. Biomolecules 11:6, pages 892.
Crossref
Crossref
Yang Ding, Zheng Li, Chenchen Xu, Wenjing Qin, Qiong Wu, Xuchun Wang, Xiamin Cheng, Lin Li & Wei Huang. (2020) Fluorogenic Probes/Inhibitors of β‐Lactamase and their Applications in Drug‐Resistant Bacteria. Angewandte Chemie International Edition 60:1, pages 24-40.
Crossref
Crossref
Yang Ding, Zheng Li, Chenchen Xu, Wenjing Qin, Qiong Wu, Xuchun Wang, Xiamin Cheng, Lin Li & Wei Huang. (2020) Fluorogenic Probes/Inhibitors of β‐Lactamase and their Applications in Drug‐Resistant Bacteria. Angewandte Chemie 133:1, pages 24-40.
Crossref
Crossref
M. Oliveira, I. Serrano & L. Tavares. 2020. Advances in Animal Health, Medicine and Production. Advances in Animal Health, Medicine and Production
279
287
.
Mojgan Sabet, Ziad Tarazi, Debora Rubio-Aparicio, Thomas G. Nolan, Jonathan Parkinson, Olga Lomovskaya, Michael N. Dudley & David C. Griffith. (2018)
Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an
In Vitro
Hollow-Fiber Model
. Antimicrobial Agents and Chemotherapy 62:2.
Crossref
Crossref
Gaëlle S. Nguenang, Armelle T. Mbaveng, Aimé G. Fankam, Hermione T. Manekeng, Paul Nayim, Brice E. N. Wamba & Victor Kuete. (2018)
Tristemma hirtum
and Five Other Cameroonian Edible Plants with Weak or No Antibacterial Effects Modulate the Activities of Antibiotics against Gram-Negative Multidrug-Resistant Phenotypes
. The Scientific World Journal 2018, pages 1-12.
Crossref
Crossref
Mojgan Sabet, Ziad Tarazi, Thomas Nolan, Jonathan Parkinson, Debora Rubio-Aparicio, Olga Lomovskaya, Michael N. Dudley & David C. Griffith. (2018) Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 62:1.
Crossref
Crossref
C.S. Moreira, A.C.J.A. Silva, J.S. Novais, A.M. Sá Figueiredo, V.F. Ferreira, D.R. da Rocha & H.C. Castro. (2017) Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds. Journal of Applied Microbiology 122:3, pages 651-662.
Crossref
Crossref
Bopha Kong, Tanmaya Joshi, Matthew J. Belousoff, Yitzhak Tor, Bim Graham & Leone Spiccia. (2016) Neomycin B-cyclen conjugates and their Zn(II) complexes as RNA-binding agents. Journal of Inorganic Biochemistry 162, pages 334-342.
Crossref
Crossref
Clare C. Walsh, Cornelia B. Landersdorfer, Michelle P. McIntosh, Anton Y. Peleg, Elizabeth B. Hirsch, Carl M. Kirkpatrick & Phillip J. Bergen. (2016)
Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of
Pseudomonas aeruginosa
, but do not suppress the emergence of fosfomycin resistance
. Journal of Antimicrobial Chemotherapy 71:8, pages 2218-2229.
Crossref
Crossref
Clare C. Walsh, Michelle P. McIntosh, Anton Y. Peleg, Carl M. Kirkpatrick & Phillip J. Bergen. (2015)
In vitro
pharmacodynamics of fosfomycin against clinical isolates of
Pseudomonas aeruginosa
. Journal of Antimicrobial Chemotherapy 70:11, pages 3042-3050.
Crossref
Crossref
Tanmaya Joshi, Zhi Xiang Voo, Bim Graham, Leone Spiccia & Lisandra L. Martin. (2015) Real-time examination of aminoglycoside activity towards bacterial mimetic membranes using Quartz Crystal Microbalance with Dissipation monitoring (QCM-D). Biochimica et Biophysica Acta (BBA) - Biomembranes 1848:2, pages 385-391.
Crossref
Crossref
Abdulrahman A. Alsultan, Elsayed Aboulmagd, Benjamin A. Evans & Sebastian G. B. Amyes. (2014) Clonal diversity of Acinetobacter baumannii from diabetic patients in Saudi Arabian hospitals. Journal of Medical Microbiology 63:11, pages 1460-1466.
Crossref
Crossref
Ilaria Serra, Mariano A. Scorciapino, Giorgia Manzo, Mariano Casu, Andrea C. Rinaldi, Samir Attoub, Milena Mechkarska & J. Michael Conlon. (2014) Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa. Peptides 61, pages 114-121.
Crossref
Crossref
Marina BorisovaJonathan GisinChristoph Mayer. (2014)
Blocking Peptidoglycan Recycling in
Pseudomonas aeruginosa
Attenuates Intrinsic Resistance to Fosfomycin
. Microbial Drug Resistance 20:3, pages 231-237.
Crossref
Crossref
Wenling Qin, Mauro Panunzio & Stefano Biondi. (2014) β-Lactam Antibiotics Renaissance. Antibiotics 3:2, pages 193-215.
Crossref
Crossref
M.I. Renteria, D.J. Biedenbach, S.K. Bouchillon, D.J. Hoban, N. Raghubir, P. Sajben & E. Mokaddas. (2014) In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007–2012. Diagnostic Microbiology and Infectious Disease 79:1, pages 54-59.
Crossref
Crossref
Richard J. FairYitzhak Tor. (2014) Antibiotics and Bacterial Resistance in the 21st Century. Perspectives in Medicinal Chemistry 6, pages PMC.S14459.
Crossref
Crossref
Jeffrey Lipman. 2014. Oh's Intensive Care Manual. Oh's Intensive Care Manual
738
742.e1
.
Joanna Ziemska, Aleksandra Rajnisz & Jolanta Solecka. (2013) New perspectives on antibacterial drug research. Open Life Sciences 8:10, pages 943-957.
Crossref
Crossref
Elisabet I. Nielsen & Lena E. Friberg. (2013) Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs. Pharmacological Reviews 65:3, pages 1053-1090.
Crossref
Crossref
Jean Carlet & Didier Pittet. (2013) Access to antibiotics: a safety and equity challenge for the next decade. Antimicrobial Resistance and Infection Control 2:1, pages 1.
Crossref
Crossref
George H. Talbot. (2013) β-Lactam antimicrobials: what have you done for me lately?. Annals of the New York Academy of Sciences 1277:1, pages 76-83.
Crossref
Crossref
Yuyun Zhao & Xingyu Jiang. (2013) Multiple strategies to activate gold nanoparticles as antibiotics. Nanoscale 5:18, pages 8340.
Crossref
Crossref
Martin B. Oleksiewicz, Gábor Nagy & Eszter Nagy. (2012) Anti-bacterial monoclonal antibodies: Back to the future?. Archives of Biochemistry and Biophysics 526:2, pages 124-131.
Crossref
Crossref
David M. Livermore. (2012) Fourteen years in resistance. International Journal of Antimicrobial Agents 39:4, pages 283-294.
Crossref
Crossref